Cargando…
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
Glutamatergic receptor expression is mostly unknown in adults with fragile X syndrome (FXS). Favorable behavioral effects of negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGluR(5)) in fmr1 knockout (KO) mouse models have not been confirmed in humans with FXS...
Autores principales: | Brašić, James R., Nandi, Ayon, Russell, David S., Jennings, Danna, Barret, Olivier, Mathur, Anil, Slifer, Keith, Sedlak, Thomas, Martin, Samuel D., Brinson, Zabecca, Vyas, Pankhuri, Seibyl, John P., Berry-Kravis, Elizabeth M., Wong, Dean F., Budimirovic, Dejan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760509/ https://www.ncbi.nlm.nih.gov/pubmed/33255214 http://dx.doi.org/10.3390/brainsci10120899 |
Ejemplares similares
-
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
por: Brašić, James Robert, et al.
Publicado: (2022) -
Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study
por: Brašić, James Robert, et al.
Publicado: (2021) -
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018) -
Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
por: Lohith, Talakad G, et al.
Publicado: (2013) -
Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
por: Budimirovic, Dejan B., et al.
Publicado: (2017)